BAR­DA chief leaves po­si­tion as agency en­ters un­prece­dent­ed vac­cine cam­paign, rais­ing ques­tions about fed­er­al Covid-19 re­sponse

Rick Bright, the head of the Bio­med­ical Ad­vanced Re­search and De­vel­op­ment Au­thor­i­ty and a lead­ing re­searcher on vac­cines and an­tivi­rals, is no longer run­ning the agency.

Bright’s sud­den de­par­ture, first re­port­ed by STAT, comes just as the agency, com­mon­ly called BAR­DA, has been thrust in­to the na­tion­al spot­light as it leads a na­tion­wide ef­fort to de­vel­op vac­cines and treat­ments for SARS-COV-2, the virus that caus­es Covid-19. Last week, the agency an­nounced an up-to $483 mil­lion agree­ment with Mod­er­na to help ush­er its vac­cine to ap­proval and scale up man­u­fac­tur­ing. That came af­ter an agree­ment with J&J to put $1 bil­lion — split be­tween the gov­ern­ment and the phar­ma com­pa­ny — be­hind their vac­cine ef­fort.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER